Anthony Bergmann

Insider Reports History

Entity
Individual
Location
C/O Capricor Therapeutics, Inc., 8840 Wilshire Blvd., 2 Nd Floor, Beverly Hills, CA
Signature
/s/ Linda Marban, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony Bergmann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CAPRICOR THERAPEUTICS, INC. CHIEF FINANCIAL OFFICER Common Stock 8.22K $11.4K $1.39 Mar 3, 2025 Direct
CAPRICOR THERAPEUTICS, INC. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 0 Mar 3, 2025 Direct

Insider Reports Filed by Anthony Bergmann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAPR CAPRICOR THERAPEUTICS, INC. Mar 3, 2025 2 $3.48K 4 Mar 4, 2025 CHIEF FINANCIAL OFFICER
CAPR CAPRICOR THERAPEUTICS, INC. Jan 2, 2025 3 $0 4 Jan 6, 2025 CHIEF FINANCIAL OFFICER
CAPR CAPRICOR THERAPEUTICS, INC. Jan 2, 2024 2 $0 4 Jan 4, 2024 CHIEF FINANCIAL OFFICER
CAPR CAPRICOR THERAPEUTICS, INC. Oct 23, 2023 2 $3.03K 4 Oct 24, 2023 CHIEF FINANCIAL OFFICER
CAPR CAPRICOR THERAPEUTICS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 CHIEF FINANCIAL OFFICER
CAPR CAPRICOR THERAPEUTICS, INC. Jan 3, 2022 1 $0 4 Jan 4, 2022 CHIEF FINANCIAL OFFICER